ClinicalTrials.govpublic full text
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
mild cognitive impairment, alzheimer disease, dementia, blood-based biomarkers, digital cognitive assessment, diagnostic screening, moca, disease-modifying therapy, older adults, early detection, montreal cognitive assessment, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867777
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.